Compare Abeona Therapeutics Inc (ABEO) vs Roblox Corp (RBLX) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs Roblox Corp — how do they compare? Abeona Therapeutics Inc trades at $6.71 (market cap $373.32M), while Roblox Corp trades at $54.52 (market cap $40.60B). The key difference: Roblox Corp is far larger — about 108.8× Abeona Therapeutics Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, Roblox Corp nearer its low. Which is the better fit depends on your goals.
| ABEO | RBLX | |
|---|---|---|
Market Cap | $373.32M | $40.60B |
Sector | Health | Media |
52-Week High | $7.23 | $141.56 |
52-Week Low | $4.17 | $41.30 |
Enterprise Value | $228.22M | $39.19B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
Roblox trades at $56.70, up 2.31% with strong technical momentum and bullish moving average signals. The company shows impressive revenue growth to $4.89 billion in 2025 and positive operating cash flow of $1.80 billion, though it remains unprofitable with a -20.69% net margin. Recent earnings beats and analyst consensus of $64.07 price target suggest upside potential, but multiple class action lawsuits filed in July 2026 create significant legal overhang.
While Roblox demonstrates strong user monetization and cash generation, profitability challenges and legal risks weigh on investor sentiment. The stock offers growth exposure but requires careful risk management given the negative earnings profile and ongoing litigation. Analyst optimism appears tempered by fundamental weaknesses and recent legal developments.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Roblox Corp
Roblox operates an online video game platform that lets young gamers create, develop, and monetize games (or experiences) for other players. The firm effectively offers its developers a hybrid of a game engine, publishing platform, online hosting and services, marketplace with payment processing, and social network. The platform is a closed garden that Roblox controls, earning revenue in multiple places while benefiting from outsourced game development. Unlike traditional video game publishers, Roblox is more focused on the creation of new tools and monetization techniques for its developers then creating new games or franchises. Roblox is increasingly focused on creating a metaverse that moves beyond games toward experiences like concerts, education, and even business management.
Read more on RBLX →
